NanoAct ™ is the labeling particles for in vitro diagnostics (IVD) newly developed by Asahi Kasei.
Utilizing our cellulose technology matured and advanced for more than 80 years, we developed the NanoAct ™ colored cellulose nano beads. Using NanoAct ™ as the labeling particles for IVD, not only having a multicolor product line but also increased sensitivity and faster detection time are expected.
Model studies
The results of hCG and Troponin I (TnI) assays are provided as reference examples.
Results of a
clinical test
of influenza test kits
The performance of commercially available kits using
NanoAct ™ is presented.
2021/9/26-9/30 2021 AACC ANNUAL SCIENTIFIC MEETING & CLINICAL LAB EXPO
CareStart™ COVID-19 Antigen test kit using NanoAct™ launched in the U.S.